ASCENBIO Trademark

Trademark Overview


On Monday, December 4, 2023, a trademark application was filed for ASCENBIO with the United States Patent and Trademark Office. The USPTO has given the ASCENBIO trademark a serial number of 98297014. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, October 28, 2024. This trademark is owned by ASCENDO BIOTECHNOLOGY CO., LTD.. The ASCENBIO trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, namely, anticancer medicines, antiinfection medicines, anti-inflammation medicines; Chinese medicine, namely, medicines made of Chinese traditional medicinal herbs; Western medicine, namely, pharmaceutical products for the treatment of cancer, infection, inflammation; Pharmaceutical preparations for the treatment of cancer, infection, inflammation; Biological preparations for use in cell cultures for medical purposes; Chemico-pharmaceutical preparations for oncology or immunology use; Chemico-pharmaceutical preparations for medical purposes, namely biological agents for the treatment of cancer, autoimmune disease; Biological reagent for medical purposes; Diagnostic test reagent for medical or veterinary purposes; Nutritional supplements; Freeze-dried food adapted for medical purposes; Enzyme nutritional supplements; Dietetic substances adapted for medical use; Herbal extract nutritional supplements; Plant extract nutritional supplements; Vitamin nutritiona...
ascenbio

General Information


Serial Number98297014
Word MarkASCENBIO
Filing DateMonday, December 4, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedicines for human purposes, namely, anticancer medicines, antiinfection medicines, anti-inflammation medicines; Chinese medicine, namely, medicines made of Chinese traditional medicinal herbs; Western medicine, namely, pharmaceutical products for the treatment of cancer, infection, inflammation; Pharmaceutical preparations for the treatment of cancer, infection, inflammation; Biological preparations for use in cell cultures for medical purposes; Chemico-pharmaceutical preparations for oncology or immunology use; Chemico-pharmaceutical preparations for medical purposes, namely biological agents for the treatment of cancer, autoimmune disease; Biological reagent for medical purposes; Diagnostic test reagent for medical or veterinary purposes; Nutritional supplements; Freeze-dried food adapted for medical purposes; Enzyme nutritional supplements; Dietetic substances adapted for medical use; Herbal extract nutritional supplements; Plant extract nutritional supplements; Vitamin nutritional supplements; Pesticide

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 4, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameASCENDO BIOTECHNOLOGY CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTaipei City 114063
TW

Trademark Events


Event DateEvent Description
Monday, December 4, 2023NEW APPLICATION ENTERED
Tuesday, February 27, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 1, 2024ASSIGNED TO EXAMINER
Monday, July 8, 2024NON-FINAL ACTION WRITTEN
Tuesday, October 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 26, 2024EXAMINERS AMENDMENT E-MAILED
Saturday, October 26, 2024EXAMINER'S AMENDMENT ENTERED
Saturday, October 26, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, July 8, 2024NON-FINAL ACTION E-MAILED
Monday, July 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, October 26, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 28, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 28, 2024LETTER OF SUSPENSION E-MAILED
Monday, October 28, 2024SUSPENSION LETTER WRITTEN